Clinical trial
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or…
NCT00276536 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00276536 |
|---|---|
| Title | Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma |
| Official title | Phase I Evaluation of Interferon-alpha-1b in Solid Tumors, Lymphoma or Myeloma |
| Acronym | IFNa |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Kidney Cancer, Lymphoma, Melanoma, Multiple Myeloma, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alpha-1b, IFN |
| Enrollment | 35 |
| Start date | Jan 1, 2001 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2004 |
| First posted | Jan 13, 2006 |
| Last update posted | Oct 14, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: